Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
3SBIO Inc	83B	30. avr 2024	0.69	+1.46
Acrux Ltd	FJY	30. avr 2024	0.05	+44.62
Actinogen Medical Limited	3AC	30. avr 2024	0.02	+16.22
Akeso Inc	4RY	30. avr 2024	5.70	-1.72
Aligos Therapeutics, Inc. - Common stock	5WK	30. avr 2024	0.67	-6.28
Alphamab Oncology (HK) Limited	3NK	30. avr 2024	0.55	-1.80
Alterity Therapeutics Ltd	PBN	30. avr 2024	0.00	0.00
AnGes Inc.	AJW	30. avr 2024	0.23	-3.33
Antengene Corporation Limited	722	30. avr 2024	0.10	+1.06
Ascletis Pharma Inc.	2VJ	30. avr 2024	0.15	+11.28
Avacta Group Plc	RTQ1	30. avr 2024	0.55	+0.93
Avecho Biotechnology Limited	OEZ	30. avr 2024	0.00	-71.43
BeiGene Ltd	49B	30. avr 2024	11.00	-0.90
Biofrontera AG	B8F	30. avr 2024	0.36	+23.97
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A.	6NQ	30. avr 2024	1.07	+0.95
Biophytis	6XB	30. avr 2024	0.00	0.00
Biotest AG	BIO3	30. avr 2024	28.70	+0.70
Bioton S.A.	7U5	30. avr 2024	0.79	+0.13
Bioventix Plc	51B	30. avr 2024	49.20	-4.47
Bone Therapeutics S.A.	BT1	30. avr 2024	0.01	-1.28
C4X Discovery Holdings plc	C4J	30. avr 2024	0.12	0.00
Cellectis	ZVA	30. avr 2024	2.38	-2.45
Celon Pharma SA	8RP	30. avr 2024	3.36	0.00
Chromadex Corp	OCD1	30. avr 2024	3.28	+3.14
Circassia Group Plc	82C	30. avr 2024	0.80	+1.27
CKLIFE SCIENCES	LSI	30. avr 2024	0.04	+7.89
Clinuvel Pharmaceuticals Ltd	UR9A	30. avr 2024	8.95	-2.19
Clinuvel Pharmaceuticals Ltd Ordinary Shares (Australia)	UR9	30. avr 2024	8.99	-5.22
Csl Ltd SPONSORED ADR (Australia)	CSJA	30. avr 2024	83.00	-0.60
CSL Ltd.	CSJ	30. avr 2024	166.08	-0.48

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.